Koers Sartorius Aktiengesellschaft Other OTC
Aandelen
SUVPF
DE0007165631
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 3,58 mld. 3,83 mld. | Omzet 2025 * | 4,02 mld. 4,3 mld. | Marktkapitalisatie | 17,35 mld. 18,55 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 214 mln. 229 mln. | Nettowinst (verlies) 2025 * | 343 mln. 367 mln. | EV/omzet 2024 * | 5,98 x |
Nettoschuld 2024 * | 4,05 mld. 4,33 mld. | Nettoschuld 2025 * | 3,82 mld. 4,08 mld. | EV/omzet 2025 * | 5,26 x |
K/w-verhouding 2024 * |
76,8
x | K/w-verhouding 2025 * |
51,8
x | Werknemers | - |
Dividendrendement 2024 * |
0,3% | Dividendrendement 2025 * |
0,4% | Vrij verhandelbaar | 35,03% |
Recentste transcriptie over Sartorius Aktiengesellschaft
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 59 | 01-05-99 | |
Chief Tech/Sci/R&D Officer | 59 | 01-01-95 | |
Volker Niebel
COO | Chief Operating Officer | 67 | 01-01-01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Ebsworth
BRD | Director/Board Member | 69 | 01-01-20 |
Director/Board Member | 75 | 29-11-11 | |
Director/Board Member | 58 | 06-04-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,19% | 2,71 mld. | |
+17,00% | 1,85 mld. | |
-0,51% | 1,66 mld. | |
+25,65% | 1,22 mld. | |
-13,90% | 989 mln. | |
-21,76% | 896 mln. | |
-19,54% | 660 mln. | |
+6,37% | 490 mln. | |
-.--% | 300 mln. |